Clinical Trial

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2025 (before its estimated October 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
To follow up the efficacy and safety of Candida antigen, bivalent HPV vaccine in treatment of common warts either mono or combined intralesional therapy
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-03-14; most recent amendment 2025-06-09.
Status change: Completed → Recruiting 2025-06-09
Status change: Recruiting → Completed 2025-04-01
Status change: Not Yet Recruiting → Recruiting 2022-07-26
Trial Details
NCT Number NCT05291845
Lead Sponsor Zagazig University
Conditions Warts, Human Papilloma Virus
Enrollment 162 participants
Start Date 2022-04-03
Primary Completion 2025-10-03 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-12